Breaking News Instant updates and real-time market news.

QCOM

Qualcomm

$85.84

2.05 (2.45%)

, NOK

Nokia

$4.94

-0.02 (-0.40%)

07:31
05/13/19
05/13
07:31
05/13/19
07:31

Qualcomm, HMD Global sign 5G multimode global patent license agreements

Qualcomm (QCOM) and HMD Global Oy announced that HMD Global has entered into a direct worldwide license arrangement with Qualcomm to cover branded single-mode and multimode devices manufactured and marketed by HMD Global under the Nokia (NOK) brand. Under the terms of the agreements, Qualcomm has granted HMD Global royalty-bearing patent licenses to develop, manufacture and sell branded 3G, 4G and 5G single-mode and multimode complete devices.

QCOM

Qualcomm

$85.84

2.05 (2.45%)

NOK

Nokia

$4.94

-0.02 (-0.40%)

  • 20

    May

  • 31

    Jul

QCOM Qualcomm
$85.84

2.05 (2.45%)

05/02/19
STFL
05/02/19
NO CHANGE
Target $96
STFL
Buy
Qualcomm price target lowered to $96 from $100 at Stifel
Stifel analyst Kevin Cassidy said he feels the most disappointing element of Qualcomm's (QCOM) Q2 report was guidance for "only" a 14% sequential increase and a 12% year-over-year decrease in QTL revenue, including a full quarter of payments from Apple (AAPL), noting that management said general weakness in smart phone shipments were offsetting Apple upside. Looking into 2020, Cassidy expects Qualcomm will lead the market in the transition to 5G and he continues recommending the shares for this transition. He keeps a Buy rating on Qualcomm shares but trimmed his price target on the stock to $96 from $100 following the company's report and guidance.
05/02/19
BOFA
05/02/19
UPGRADE
Target $105
BOFA
Buy
BofA/Merrill upgrades Qualcomm to Buy, sees Q3 as likely trough
As previously reported, BofA Merrill Lynch analyst Tal Liani upgraded Qualcomm to Buy from Neutral, stating that he reduced estimates based on the company's "weak" Q3 guidance, but he believes that the quarter will mark a trough ahead of the upcoming 5G handset cycle. The smartphone industry is between cellular cycles, but "Qualcomm's trajectory seems promising," Liani tells investors, adding that he expects QCT growth to accelerate on ramping 5G units, higher average selling prices, and greater attach rates for RF front-end solutions. Liani raised his price target on Qualcomm shares to $105 from $90.
05/02/19
05/02/19
UPGRADE
Target $115

Strong Buy
Qualcomm upgraded to Strong Buy at Raymond James
As previously reported, Raymond James upgraded Qualcomm to Strong Buy from Outperform and raised its price target to $115 from $86. Analyst Chris Caso has increased confidence in management's ability to unlock value following the Apple (AAPL) litigation settlement and the 5G smartphone cycle, and believes Apple's payments equate to $7.50 per phone, inline with his expectations.
05/02/19
05/02/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Clorox (CLX) upgraded to Hold from Sell at Deutsche Bank with analyst Steve Powers saying he views the company's fiscal Q3 results as "disappointing" but believes most of his concerns around competition are now more fairly priced into the shares. 2. Arconic (ARNC) upgraded to Buy from Neutral at Goldman Sachs with analyst Matthew Korn saying the company is benefiting from "strategic clarity." 3. Qualcomm (QCOM) was upgraded to Strong Buy from Outperform at Raymond James and to Buy from Neutral at BofA/Merrill. 4. Zynga (ZNGA) upgraded to Outperform from Neutral at Baird with analyst Colin Sebastian saying last night's better than expected Q1 results largely confirm the company's successful turnaround and acquisition strategy, improving organic growth outlook, and its reduced dependence on new game launches. 5. WWE (WWE) upgraded to Buy from Hold at Loop Capital with analyst Alan Gould saying he is taking advantage of the recent pullback in the stock price driven by the "temporary" and "unusual" amount of talent injuries. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NOK Nokia
$4.94

-0.02 (-0.40%)

03/26/19
MKMP
03/26/19
NO CHANGE
Target $8
MKMP
Buy
Nokia a top pick for 'steadily moving forward' 5G market, says MKM Partners
MKM Partners analyst Michael Genovese kept his Buy rating and $8 price target on Nokia (NOK), maintaining his view of the company as the "top pick for 5G", which he sees as "steadily moving forward". The analyst notes that the stock outperformed the Nasdaq by 10% over the past 6 months but underperformed the index by 8% over the past 3 months on investors perceptions that the rollout is proceeding slowly. Genovese adds that the most recent headwinds of wrongdoing in the company's Alcatel-Lucent transactions are unlikely to be material, and maintains that Nokia should be favored over Ericson (ERIC) in 5G because of its "greater exposure to IP Routing, Optical and Wireline".
04/15/19
GSCO
04/15/19
DOWNGRADE
Target $5.5
GSCO
Sell
Nokia downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Alexander Duval downgraded Nokia to Sell from Neutral and cut his price target for the shares to $5.50 from $6.40.
04/15/19
GSCO
04/15/19
DOWNGRADE
Target $5.5
GSCO
Sell
Goldman sees risks to Nokia estimates, downgrades shares to Sell
Goldman Sachs analyst Alexander Duval downgraded Nokia (NOK) to Sell from Neutral and cut his price target for the shares to $5.50 from $6.40. Consensus estimates have further downside as analysts factor in lower Networks revenues, a more conservative margin trajectory and "more muted" growth in the Nokia's "highly profitable" Patents business, Duval tells investors in a research note. The analyst reduced his Networks growth rate on "subseasonal" growth in the first half of 2019 as well as management's "cautious" statements. Duval says these contrast with his industry discussions suggesting a wireless market growth inflection, due to 5G. He sees risks to Nokia's market share "given newsflow implying share gains by its main competitor, Ericsson" (ERIC).
05/07/19
BMOC
05/07/19
NO CHANGE
Target $28
BMOC
Outperform
Marvell price target raised to $28 from $22 at BMO Capital
BMO Capital analyst Ambrish Srivastava raised his price target on Marvell (MRVL) to $28 and kept his Outperform rating, citing the "attractive valuation" and the recent underperformance of the shares. The analyst is also positive on the company's attractive free cash flow yield, potential for communications infrastructure industry design activity wins, and his expected 35c EPS accretion from its Samsung (SSNLF) and Nokia (NOK) contract wins.

TODAY'S FREE FLY STORIES

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.87

-0.055 (-2.86%)

16:50
08/23/19
08/23
16:50
08/23/19
16:50
Hot Stocks
Ra Medical Systems discloses NYSE notice related to 10-Q filing delay »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$35.73

-0.81 (-2.22%)

16:47
08/23/19
08/23
16:47
08/23/19
16:47
Syndicate
Breaking Syndicate news story on Pembina Pipeline »

Pembina Pipeline files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

APEN

Apollo Endosurgery

$3.50

(0.00%)

16:44
08/23/19
08/23
16:44
08/23/19
16:44
Syndicate
Breaking Syndicate news story on Apollo Endosurgery »

Apollo Endosurgery files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
08/23/19
08/23
16:40
08/23/19
16:40
General news
Fed's Clarida said the global economy has worsened »

Fed's Clarida said…

LQDA

Liquidia Technologies

$5.23

-0.38 (-6.77%)

16:35
08/23/19
08/23
16:35
08/23/19
16:35
Syndicate
Breaking Syndicate news story on Liquidia Technologies »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$175.24

-4.91 (-2.73%)

16:32
08/23/19
08/23
16:32
08/23/19
16:32
Hot Stocks
Visa CFO Prabhu sells over 25,000 class A common shares »

Visa vice chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 27

    Oct

QCOM

Qualcomm

$73.57

-3.55 (-4.60%)

16:31
08/23/19
08/23
16:31
08/23/19
16:31
Hot Stocks
Qualcomm CFO Dave Wise to retire, Akash Palkhiwala named interim CFO »

Qualcomm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 06

    Nov

ANFI

Amira Nature Foods

$0.58

-0.0144 (-2.44%)

16:30
08/23/19
08/23
16:30
08/23/19
16:30
Hot Stocks
Amira Nature Foods receives NYSE notice over late Form 20-F filing »

Amira Nature Food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.